

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced a conditional placing with institutional investors on Friday, to raise at...


Diurnal Group Names Director Sam Williams Interim Chair


Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle


(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Thursday that its new drug application (NDA) for 'Alkindi', or hydroco...


(Sharecast News) - Speciality pharmaceutical company Diurnal Group narrowed its first-half loss by 53% to ?4.6m, it announced on Tuesday, which it sai...


Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi


UK Earnings, Trading Statements Calendar - Next 7 Days


Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress